Global Preconception and Contraception Care: Using a Life-Course Approach to Improve Health Outcomes in Lower-Resource Settings.
| Autor: | Cohen MA; Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA; Division of Complex Family Planning, Department of Gynecology and Obstetrics, Emory University School of Medicine, 49 Jesse Hill Jr. Drive, SE - Faculty Office Building. Atlanta, GA 30303, USA. Electronic address: megan.a.cohen@emory.edu., Kumar S; Jhpiego India, New Delhi, India; Technical Leadership and Innovations, Jhpiego, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Hathaway M; Johns Hopkins University, Baltimore, MD, USA; Carafem, Washington, DC, USA; Jhpiego, Baltimore, MD, USA; Unity Health Care, Inc, Washington, DC, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Obstetrics and gynecology clinics of North America [Obstet Gynecol Clin North Am] 2022 Dec; Vol. 49 (4), pp. 647-663. |
| DOI: | 10.1016/j.ogc.2022.07.003 |
| Abstrakt: | A life-course approach incorporating appropriate preconception and contraception care is key to achieving optimal maternal, neonatal, and child health outcomes. In low- and middle-income countries (LMIC), there is a large unmet need for contraception and an estimated 49% of pregnancies are unintended. In this article, we discuss preconception and contraception care in LMIC settings including key recommendations for content and service delivery. We discuss barriers and facilitators to contraceptive provision, discuss considerations for providers who may practice in LMIC settings, and highlight strategies for achieving increased contraceptive uptake including several examples of successful programs. Competing Interests: Disclosure Megan Cohen has been a trainer for AccessMatters. Mark Hathaway is a Nexplanon trainer for Organon and clinical advisory board member for Afaxys. He was previously on speakers’ bureaus for Medicines360 and Bayer, but these affiliations ended in December 2021. Somesh Kumar has no conflicts to disclose. (Copyright © 2022 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|